Carol Feghali‐Bostwick

13.4k total citations · 2 hit papers
176 papers, 9.9k citations indexed

About

Carol Feghali‐Bostwick is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Carol Feghali‐Bostwick has authored 176 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 82 papers in Pathology and Forensic Medicine and 57 papers in Molecular Biology. Recurrent topics in Carol Feghali‐Bostwick's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (103 papers), Systemic Sclerosis and Related Diseases (82 papers) and Pulmonary Hypertension Research and Treatments (24 papers). Carol Feghali‐Bostwick is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (103 papers), Systemic Sclerosis and Related Diseases (82 papers) and Pulmonary Hypertension Research and Treatments (24 papers). Carol Feghali‐Bostwick collaborates with scholars based in United States, United Kingdom and Japan. Carol Feghali‐Bostwick's co-authors include Joseph M. Pilewski, Thomas A. Medsger, Augustine M.K. Choi, John Varga, Yingze Zhang, Robert Lafyatis, Naftali Kaminski, Timothy M. Wright, G. R. Scott Budinger and William R. Coward and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Carol Feghali‐Bostwick

173 papers receiving 9.8k citations

Hit Papers

Mechanosignaling through YAP and TAZ drives fibroblast ac... 2012 2026 2016 2021 2014 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
    2014 617 citations Fei Liu, David Lagares et al. American Journal of Physiology-Lung Cellular and Molecular Physiology profile →
  2. Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling
    2012 309 citations Carol Feghali‐Bostwick, Gökhan M. Mutlu et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Feghali‐Bostwick United States 56 4.1k 3.6k 2.7k 1.4k 1.3k 176 9.9k
Jochen Zwerina Austria 64 1.8k 0.4× 4.9k 1.4× 1.6k 0.6× 2.3k 1.6× 702 0.5× 229 12.2k
Yoshihide Asano Japan 54 1.6k 0.4× 3.0k 0.8× 4.1k 1.5× 3.0k 2.1× 1.6k 1.2× 434 10.3k
Tsuneyo Mimori Japan 59 1.8k 0.4× 3.2k 0.9× 1.9k 0.7× 3.2k 2.2× 4.9k 3.7× 396 12.9k
Yusuke Nakamura Japan 54 1.1k 0.3× 4.6k 1.3× 1.3k 0.5× 1.5k 1.0× 1.1k 0.8× 160 10.4k
Peiguo Chu United States 49 2.0k 0.5× 2.7k 0.8× 1.4k 0.5× 1.1k 0.7× 691 0.5× 151 8.6k
Yoji Nagashima Japan 54 3.4k 0.8× 5.7k 1.6× 540 0.2× 840 0.6× 1.1k 0.8× 415 11.3k
Renate E. Gay Switzerland 65 1.2k 0.3× 5.5k 1.5× 1.9k 0.7× 3.5k 2.4× 857 0.6× 174 13.4k
Wayne A. Border United States 58 2.1k 0.5× 6.7k 1.9× 957 0.4× 1.4k 0.9× 736 0.6× 118 17.0k
Yuzuru Kanakura Japan 58 3.0k 0.7× 4.6k 1.3× 1.1k 0.4× 5.3k 3.7× 697 0.5× 368 16.5k
Iván O. Rosas United States 49 6.3k 1.5× 2.2k 0.6× 638 0.2× 1.0k 0.7× 1.1k 0.9× 190 9.5k

Countries citing papers authored by Carol Feghali‐Bostwick

Since Specialization
Citations

This map shows the geographic impact of Carol Feghali‐Bostwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Feghali‐Bostwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Feghali‐Bostwick more than expected).

Fields of papers citing papers by Carol Feghali‐Bostwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Feghali‐Bostwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Feghali‐Bostwick. The network helps show where Carol Feghali‐Bostwick may publish in the future.

Co-authorship network of co-authors of Carol Feghali‐Bostwick

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Feghali‐Bostwick. A scholar is included among the top collaborators of Carol Feghali‐Bostwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Feghali‐Bostwick. Carol Feghali‐Bostwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frost, DeAnna Baker, et al.. (2024). The Relationship between Time, Race, and Estrogen Receptor Alpha in Estradiol-Induced Dermal Fibrosis. Biomedicines. 12(1). 182–182. 2 indexed citations
2.
Angel, Peggi M., Evelyn Bruner, Jennifer R. Bethard, et al.. (2019). Extracellular matrix alterations in low‐grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry. Journal of Mass Spectrometry. 55(4). e4450–e4450. 31 indexed citations
3.
Ward, Christopher, et al.. (2019). Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH). SHILAP Revista de lepidopterología. 1 indexed citations
4.
Nanri, Yasuhiro, Satoshi Nunomura, Yasuhiro Terasaki, et al.. (2019). Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(2). 204–216. 45 indexed citations
5.
Christmann, Romy, Percival D. Sampaio‐Barros, Carlos Roberto Ribeiro de Carvalho, et al.. (2016). miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Research & Therapy. 18(1). 155–155. 85 indexed citations
6.
Fan, Ming-Hui, Huihua Li, Hyun-Jeong Ra, et al.. (2015). Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice. Journal of Biological Chemistry. 291(15). 8070–8089. 81 indexed citations
7.
Ahluwalia, Neil, Paula Grasberger, Carol Feghali‐Bostwick, et al.. (2015). Fibrogenic Lung Injury Induces Non–Cell-Autonomous Fibroblast Invasion. American Journal of Respiratory Cell and Molecular Biology. 54(6). 831–842. 23 indexed citations
8.
Tafaleng, Edgar N., Souvik Chakraborty, Bing Han, et al.. (2015). Induced pluripotent stem cells model personalized variations in liver disease resulting from α1‐antitrypsin deficiency. Hepatology. 62(1). 147–157. 62 indexed citations
9.
Liu, Fei, David Lagares, Kyoung Moo Choi, et al.. (2014). Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(4). L344–L357. 617 indexed citations breakdown →
10.
Liu, Tianju, Matthew Ullenbruch, Yoon Young Choi, et al.. (2013). Telomerase and Telomere Length in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 49(2). 260–268. 71 indexed citations
11.
Ikari, Jun, Joel Michalski, Shunichiro Iwasawa, et al.. (2013). Phosphodiesterase-4 Inhibition Augments Human Lung Fibroblast Vascular Endothelial Growth Factor Production Induced by Prostaglandin E2. American Journal of Respiratory Cell and Molecular Biology. 49(4). 571–581. 11 indexed citations
12.
Reilkoff, Ronald A., Hong Peng, Lynne A. Murray, et al.. (2012). Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 187(2). 180–188. 97 indexed citations
13.
Bhattacharyya, Swati, Kathleen Kelley, Denisa S. Melichian, et al.. (2012). Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses. American Journal Of Pathology. 182(1). 192–205. 209 indexed citations
14.
Lee, Seon‐Jin, Lanping Guo, Molong Li, et al.. (2010). Autophagic Protein LC3B Confers Resistance against Hypoxia-induced Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 183(5). 649–658. 180 indexed citations
15.
Coward, William R., et al.. (2009). Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis. Molecular and Cellular Biology. 29(15). 4325–4339. 146 indexed citations
16.
Veraldi, Kristen L., Hidekata Yasuoka, Michael M. Myerburg, et al.. (2009). Role of Insulin-like Growth Factor Binding Protein-3 in Allergic Airway Remodeling. American Journal of Respiratory and Critical Care Medicine. 180(7). 611–617. 31 indexed citations
17.
Feghali‐Bostwick, Carol, Leo E. Otterbein, Joseph M. Pilewski, et al.. (2007). Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 177(2). 156–163. 205 indexed citations
18.
Horan, Gerald, Susan Wood, Victor Ona, et al.. (2007). Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. American Journal of Respiratory and Critical Care Medicine. 177(1). 56–65. 331 indexed citations
19.
Bogatkevich, Galina S., Kristin B. Highland, Faye N. Hant, et al.. (2007). Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: Possible role in systemic sclerosis. Arthritis & Rheumatism. 56(7). 2432–2442. 29 indexed citations
20.
Wang, Xiao Mei, Yingze Zhang, Hong Pyo Kim, et al.. (2006). Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. The Journal of Experimental Medicine. 203(13). 2895–2906. 325 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Zwerina Breakdown of academic impact, for papers by Yoshihide Asano Breakdown of academic impact, for papers by Tsuneyo Mimori Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Peiguo Chu Breakdown of academic impact, for papers by Yoji Nagashima Breakdown of academic impact, for papers by Renate E. Gay Breakdown of academic impact, for papers by Wayne A. Border Breakdown of academic impact, for papers by Yuzuru Kanakura Breakdown of academic impact, for papers by Iván O. Rosas
Rankless by CCL
2026